Hunkapiller purchased 100,000 shares of Pacific Biosciences of California stock on the open market
(Posted by Joseph Griffin on Dec 13th, 2013 Pacific Biosciences of California (NASDAQ:PACB) CEO Michael Hunkapiller purchased 100,000 shares of Pacific Biosciences of California stock on the open market in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $4.13 per share, with a total value of $413,000.00. Following the acquisition, the chief executive officer now directly owns 1,800,000 shares in the company, valued at approximately $7,434,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. on IHUB.
Separately, analysts at Maxim Group raised their price target on shares of Pacific Biosciences of California from $4.00 to $8.00 in a research note to investors on Thursday, September 26th. They now have a “buy” rating on the stock.
(same link as last).